Liver abscess case report: A patient who developed an amoebic liver abscess during treatment with interferon

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 10, 1998, Pages 1068-1071

  Matsuo, Taku ^a   Shinzawa, Haruhide ^a   Sugahara, Kazuhiko ^a   Mitsuhashi, Hideki ^a   Watanabe, Hisayoshi ^a   Abe, Takashi ^a   Ohno, Shigeru ^a   Terashita, Masaki ^a   Saito, Kouji ^a   Saito, Takafumi ^a   Misawa, Hiroyuki ^a   Togashi, Hitoshi ^a   Takahashi, Tsuneo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Amoebic liver abscess; Chronic hepatitis C; Interferon therapy

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA INTERFERON A; ANTIVIRUS AGENT;

ABDOMINAL SCINTISCANNING; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENTAMOEBA HISTOLYTICA; FEMALE; FEVER; HEPATITIS C; HUMAN; IMMUNOTHERAPY; INFECTION SENSITIVITY; LIVER AMEBIASIS; PARASITE IDENTIFICATION; PRIORITY JOURNAL; TREATMENT OUTCOME; FATALITY;

AGED; ANTIVIRAL AGENTS; FATAL OUTCOME; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER ABSCESS, AMEBIC;

EID: 0032174854     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00572.x     Document Type: Article

References (20)

1. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon. J. Hepatol 1996; 24: 38-47.
2. Okanoue T, Sakamoto S, Itoh Y et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J. Hepatol. 1996; 25: 283-91.
3. Okuno H, Ikeda H, Fukushima S et al. A case of tuberculous pleurisy aggravated by interferon treatment for chronic hepatitis C. Jpn J. Gastroenterol. 1995; 92: 1071-5.
4. Sargeaunt PG, Oates JK, Oriel JD, MacLennan I, Goldmeier D. Entamoeba histolytica in male homosexuals. Br. J. Vener. Dis. 1983; 59: 193-5.
5. Markell EK, Havens RF, Kuritsubo RA, Wingerd J. Intestinal Protozoa in homosexual men in the San Francisco bay area: Prevalence and correlates of infection. Am. J. Trop. Med. Hyg. 1984; 33: 239-45.
6. Lee KC, Yamazaki O, Hamba H et al. Analysis of 69 patients with amebic liver abscess. J. Gastroenterol. 1996; 31: 40-5.
7. Brumpt E. Etude sommaire de l'Entamoeba dispar n. sp. amibe a kystes quadrinuclees, parasite de l'homme. Bull. Acad. Natl Med. 1925; 94: 942-52.
8. Lin JY, Chadee K. Macrophage cytotoxity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine. J. Immunol. 1992; 148: 3999-4005.
9. Lin JY, Seguin R, Keller K, Chadee K. Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect. Immun. 1994; 62: 1534-41.
10. Wang W, Keller K, Chadee K. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production for cytotoxicity against amoebae and tumor cells. Immunology 1994; 83: 601-10.
11. Seguin R, Keller K, Chadee K. Entamoeba histolytica stimulates the unstable transcription of c-fos and tumor necrosis factor-α-mRNA by protein kinase C signal transduction in macrophages. Immunology 1995; 86: 49-57.
12. Handa T, Mitsuyama M, Serushago A, Muramori K, Nomoto K. Cooperative effect of MCF and MAF (IFN-γ) in the protection of mice against Listeria monocytogenes. Immunology 1988; 65: 427-32.
13. Ucla C, Roux-Lombard P, Fey S, Dayer JM, Mach B. Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells. J. Clin. Invest. 1990; 85: 185-91.
14. Bogdan C, Moll H, Solbach W, Rollinghoff M. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 1990; 20: 1131-5.
15. Daito K, Suou T, Kawasaki H. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon. Res. Comun. Chem. Pathol. Pharmacol. 1994; 83: 303-16.
16. Lohr HF, Weber W, Schlaak J et al. Proliferative response of CD4+ T cells and hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology 1995; 22: 61-8.
17. Arany I, Tyring SK. Activation of local cell-mediated immunity in interferon-responsive patients with human papilloma-associated lesions. J. Interferon Cytokine Res. 1996; 16: 453-60.
18. Reed S, Bouvier J, Pollack AS et al. Cloning of a virulence factor of Entamoeba histolytica. J. Clin. Invest. 1993; 91: 1532-40.
19. Ellen LI, Yang W, Zhang T, Stanley SL. Interaction of laminin with Entamoeba histolytica cystein proteinases and its effect on amebic pathogenesis. Infect. Immun. 1995; 63: 4150-3.
20. Buchbinder SP, Katz MH, Hessol NA et al. Hepatitis C virus infection in sexually active homosexual men. J. Infect. 1994; 29: 263-9.